Intrahepatic Cholestasis in Non-Alcoholic Fatty Liver Disease: Pathogenesis and Role of Ademetionine in Treatment
Aim: to evaluate features of intrahepatic cholestasis (IHC) pathogenesis in non-alcoholic fatty liver disease (NAFLD), as well as role of ademetionine in treatment of this condition.Key statements. NAFLD is the most frequent chronic diffuse liver disease. Increase in proportion of people with excess...
Saved in:
| Main Author: | Ye. N. Shirokova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Gastro LLC
2023-08-01
|
| Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| Subjects: | |
| Online Access: | https://www.gastro-j.ru/jour/article/view/830 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The debut of benign recurrent intrahepatic cholestasis in acute hepatitis A
by: K. Yu. Kokina, et al.
Published: (2024-12-01) -
Cholestasis in Chronic Liver Disease and the Role of Ademetionine in its Treatment (Literature Review and Expert Panel Resolution)
by: K. L. Raikhelson, et al.
Published: (2024-10-01) -
Clinical outcomes of surgical management for rare types of progressive familial intrahepatic cholestasis: a case series
by: Kazunori Masahata, et al.
Published: (2022-01-01) -
Comparative analysis of vitamin K levels in women with intrahepatic cholestasis of pregnancy
by: Maria Cemortan, et al.
Published: (2025-04-01) -
The effect of twin pregnancy in intrahepatic cholestasis of pregnancy: A case control study
by: Silja Maigaard Axelsen, et al.
Published: (2024-10-01)